This effect is believed to occur due to the release of a wide range of tumor-associated antigens and damage-related molecular patterns (e.g., heat shock proteins, HMGB1) into the tumor microenvironment, which encourage dendritic cell activation and subsequent T-cell priming, thereby strengthening anti-tumor immune responses [30]. This evidence concerns the gene HMGB1 and neoplasm.